Global Distribution ManaMed has a Denton HQ and a 2021 expansion into Botswana, signaling a growing international distribution footprint. This creates sales opportunities with orthopedists, physical therapists, surgeons, and DME companies across the US, Africa, and other markets. Focus on partnerships to supply orthopedic mobility devices, DVT prevention, vascular therapy, and post-op rehab products through distributors and hospital networks.

New Product Push Three product launches on Jan 17, 2025 (ManaGo 71, ManoFX, ManaCold Platinum 2.0) present immediate cross-sell and bundling opportunities. Target existing customers with upgrade paths and new clinical applications; tailor campaigns to post-op rehab, vascular therapy, and mobility needs; pair with DVT prevention devices in bundled kits for hospitals and clinics.

Reimbursement Advantage ManaMed offers HCPCS coding suggestions via Medicare through its coding verification process, reducing procurement friction for clinics. Sales opportunities include offering reimbursement workshops, co-marketing with clinics, and providing ready-to-submit coding guidance to procurement teams, driving faster adoption of new devices.

Care Continuum The portfolio spans bracing, vascular therapy, assisted mobility, electrical stimulation, maternity, and DVT prevention, enabling end-to-end care from active living to postoperative rehabilitation. Position ManaMed as an integrated supplier for hospitals, surgical centers, PT networks, and DME providers, with cross-category bundles spanning mobility aids and rehab devices to boost average order value.

Service Advantage ManaMed emphasizes market-leading customer service, a seamless ordering portal, flexible scheduling, and responsive support. Leverage these capabilities to win procurement contracts with hospital systems and large clinics, offering API/EDI-friendly ordering, bulk pricing, and staff training to ensure high retention.